These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 28800074

  • 1. Phellinus linteus Grown on Germinated Brown Rice Increases Cetuximab Sensitivity of KRAS-Mutated Colon Cancer.
    Park HJ, Park JB, Lee SJ, Song M.
    Int J Mol Sci; 2017 Aug 11; 18(8):. PubMed ID: 28800074
    [Abstract] [Full Text] [Related]

  • 2. Antibody-mediated delivery of anti-KRAS-siRNA in vivo overcomes therapy resistance in colon cancer.
    Bäumer S, Bäumer N, Appel N, Terheyden L, Fremerey J, Schelhaas S, Wardelmann E, Buchholz F, Berdel WE, Müller-Tidow C.
    Clin Cancer Res; 2015 Mar 15; 21(6):1383-94. PubMed ID: 25589625
    [Abstract] [Full Text] [Related]

  • 3. Effect of simvastatin on cetuximab resistance in human colorectal cancer with KRAS mutations.
    Lee J, Lee I, Han B, Park JO, Jang J, Park C, Kang WK.
    J Natl Cancer Inst; 2011 Apr 20; 103(8):674-88. PubMed ID: 21398618
    [Abstract] [Full Text] [Related]

  • 4. The ethyl acetate extract of Phellinus linteus grown on germinated brown rice induces G0/G1 cell cycle arrest and apoptosis in human colon carcinoma HT29 cells.
    Park HJ, Choi SY, Hong SM, Hwang SG, Park DK.
    Phytother Res; 2010 Jul 20; 24(7):1019-26. PubMed ID: 19998418
    [Abstract] [Full Text] [Related]

  • 5. L-Ascorbic acid can abrogate SVCT-2-dependent cetuximab resistance mediated by mutant KRAS in human colon cancer cells.
    Jung SA, Lee DH, Moon JH, Hong SW, Shin JS, Hwang IY, Shin YJ, Kim JH, Gong EY, Kim SM, Lee EY, Lee S, Kim JE, Kim KP, Hong YS, Lee JS, Jin DH, Kim T, Lee WJ.
    Free Radic Biol Med; 2016 Jun 20; 95():200-8. PubMed ID: 27012422
    [Abstract] [Full Text] [Related]

  • 6. Cordyceps militaris Grown on Germinated Soybean Suppresses KRAS-Driven Colorectal Cancer by Inhibiting the RAS/ERK Pathway.
    Seo H, Song J, Kim M, Han DW, Park HJ, Song M.
    Nutrients; 2018 Dec 21; 11(1):. PubMed ID: 30577618
    [Abstract] [Full Text] [Related]

  • 7. Targeting the PI3K signaling pathway in KRAS mutant colon cancer.
    Hong S, Kim S, Kim HY, Kang M, Jang HH, Lee WS.
    Cancer Med; 2016 Feb 21; 5(2):248-55. PubMed ID: 26715098
    [Abstract] [Full Text] [Related]

  • 8. The Akt inhibitor ISC-4 synergizes with cetuximab in 5-FU-resistant colon cancer.
    Allen JE, Gallant JN, Dicker DT, Amin S, Irby RB, Sharma AK, El-Deiry WS.
    PLoS One; 2013 Feb 21; 8(3):e59380. PubMed ID: 23555026
    [Abstract] [Full Text] [Related]

  • 9. Honokiol enhances the sensitivity of cetuximab in KRASG13D mutant colorectal cancer through destroying SNX3-retromer complex.
    Zhu Q, Zhang R, Gu X, Zhao Z, Gao Q, Chen M, Wu Q, Xie T, Sui X.
    Theranostics; 2024 Feb 21; 14(14):5443-5460. PubMed ID: 39310106
    [Abstract] [Full Text] [Related]

  • 10. Cetuximab Enhances the Efficacy of MRTX1133, a Novel KRASG12D Inhibitor, in Colorectal Cancer Treatment.
    Kataoka M, Kitazawa M, Nakamura S, Koyama M, Yamamoto Y, Miyazaki S, Hondo N, Tanaka H, Soejima Y.
    Anticancer Res; 2023 Oct 21; 43(10):4341-4348. PubMed ID: 37772552
    [Abstract] [Full Text] [Related]

  • 11. CD16-158-valine chimeric receptor T cells overcome the resistance of KRAS-mutated colorectal carcinoma cells to cetuximab.
    Arriga R, Caratelli S, Lanzilli G, Ottaviani A, Cenciarelli C, Sconocchia T, Spagnoli GC, Iezzi G, Roselli M, Lauro D, Coppola A, Dotti G, Ferrone S, Sconocchia G.
    Int J Cancer; 2020 May 01; 146(9):2531-2538. PubMed ID: 31396956
    [Abstract] [Full Text] [Related]

  • 12. Lauric acid can improve the sensitization of Cetuximab in KRAS/BRAF mutated colorectal cancer cells by retrievable microRNA-378 expression.
    Weng WH, Leung WH, Pang YJ, Hsu HH.
    Oncol Rep; 2016 Jan 01; 35(1):107-16. PubMed ID: 26496897
    [Abstract] [Full Text] [Related]

  • 13. Primary tumor location is an important predictive factor for wild-type KRAS metastatic colon cancer treated with cetuximab as front-line bio-therapy.
    Lu HJ, Lin JK, Chen WS, Jiang JK, Yang SH, Lan YT, Lin CC, Chang SC, Teng HW.
    Asia Pac J Clin Oncol; 2016 Sep 01; 12(3):207-15. PubMed ID: 26935130
    [Abstract] [Full Text] [Related]

  • 14. Digitoxin promotes apoptosis and inhibits proliferation and migration by reducing HIF-1α and STAT3 in KRAS mutant human colon cancer cells.
    Mi C, Cao X, Ma K, Wei M, Xu W, Lin Y, Zhang J, Wang TY.
    Chem Biol Interact; 2022 Jan 05; 351():109729. PubMed ID: 34717917
    [Abstract] [Full Text] [Related]

  • 15. Primary and Acquired Resistance of Colorectal Cancer to Anti-EGFR Monoclonal Antibody Can Be Overcome by Combined Treatment of Regorafenib with Cetuximab.
    Napolitano S, Martini G, Rinaldi B, Martinelli E, Donniacuo M, Berrino L, Vitagliano D, Morgillo F, Barra G, De Palma R, Merolla F, Ciardiello F, Troiani T.
    Clin Cancer Res; 2015 Jul 01; 21(13):2975-83. PubMed ID: 25838391
    [Abstract] [Full Text] [Related]

  • 16. Novel toll-like receptor 9 agonist induces epidermal growth factor receptor (EGFR) inhibition and synergistic antitumor activity with EGFR inhibitors.
    Damiano V, Caputo R, Bianco R, D'Armiento FP, Leonardi A, De Placido S, Bianco AR, Agrawal S, Ciardiello F, Tortora G.
    Clin Cancer Res; 2006 Jan 15; 12(2):577-83. PubMed ID: 16428503
    [Abstract] [Full Text] [Related]

  • 17. miR-143 or miR-145 overexpression increases cetuximab-mediated antibody-dependent cellular cytotoxicity in human colon cancer cells.
    Gomes SE, Simões AE, Pereira DM, Castro RE, Rodrigues CM, Borralho PM.
    Oncotarget; 2016 Feb 23; 7(8):9368-87. PubMed ID: 26824186
    [Abstract] [Full Text] [Related]

  • 18. Targeting RAS signaling pathway as a potential therapeutic target in the treatment of colorectal cancer.
    Bahrami A, Hassanian SM, ShahidSales S, Farjami Z, Hasanzadeh M, Anvari K, Aledavood A, Maftouh M, Ferns GA, Khazaei M, Avan A.
    J Cell Physiol; 2018 Mar 23; 233(3):2058-2066. PubMed ID: 28262927
    [Abstract] [Full Text] [Related]

  • 19. Synergistic Approach of Antibody-Photosensitizer Conjugate Independent of KRAS-Mutation and Its Downstream Blockade Pathway in Colorectal Cancer.
    Ahn M, Lee T, Kim KS, Lee S, Na K.
    Adv Healthc Mater; 2023 Dec 23; 12(31):e2302374. PubMed ID: 37722358
    [Abstract] [Full Text] [Related]

  • 20. Antrodia camphorata grown on germinated brown rice inhibits HT-29 human colon carcinoma proliferation through inducing G0/G1 phase arrest and apoptosis by targeting the β-catenin signaling.
    Park DK, Lim YH, Park HJ.
    J Med Food; 2013 Aug 23; 16(8):681-91. PubMed ID: 23957353
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.